Suppr超能文献

欧洲继发性骨折预防中治疗起始的长期趋势:一项包括丹麦、加泰罗尼亚和英国数据的多国队列研究。

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom.

机构信息

Department of Medicine, Hospital of Holbaek, Holbaek, Region Zealand, Denmark.

Department of Medicine, Hospital of Slagelse, Slagelse, Region Zealand, Denmark.

出版信息

Osteoporos Int. 2020 Aug;31(8):1535-1544. doi: 10.1007/s00198-020-05358-4. Epub 2020 Mar 17.

Abstract

UNLABELLED

This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88-90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. Improved post-fracture care is needed.

INTRODUCTION

Patients experiencing a fragility fracture are at high risk of subsequent fractures, particularly within the first 2 years after the fracture. Previous studies have demonstrated that only a small proportion of fracture patients initiate therapy with an anti-osteoporotic medication (AOM), despite the proven fracture risk reduction of such therapies. The aim of this paper is to evaluate the changes in this post-fracture treatment gap across three different countries from 2005 to 2015.

METHODS

This analysis, which is part of a multinational cohort study, included men and women, aged 50 years or older, sustaining a first incident fragility fracture. Using routinely collected patient data from three administrative health databases covering Catalonia, Denmark, and the United Kingdom, we estimated the treatment gap as the proportion of patients not treated with AOM within 1 year of their first incident fracture.

RESULTS

A total of 648,369 fracture patients were included. Mean age 70.2-78.9 years; 22.2-31.7% were men. In Denmark, the treatment gap was stable at approximately 88-90% throughout the 2005 to 2015 time period. In Catalonia, the treatment gap increased from 80 to 88%. In the UK, an initially decreasing treatment gap-though never smaller than 63%-was replaced by an increasing gap towards the end of our study. The gap was more pronounced in men than in women.

CONCLUSION

Despite repeated calls for improved secondary fracture prevention, an unacceptably large treatment gap remains, with time trends indicating that the problem may be getting worse in recent years.

摘要

未加标签

本文展示了 2005 年至 2015 年期间,骨折后抗骨质疏松治疗存在较大差距。丹麦的差距一直稳定在 88-90%左右,加泰罗尼亚从 80%增加到 88%,而英国在研究末期开始增加。需要改善骨折后的护理。

简介

经历脆性骨折的患者有发生后续骨折的高风险,特别是在骨折后 2 年内。先前的研究表明,尽管这些治疗方法可降低骨折风险,但只有一小部分骨折患者开始接受抗骨质疏松药物(AOM)治疗。本文的目的是评估 2005 年至 2015 年期间,三个不同国家的这一骨折后治疗差距的变化。

方法

这是一项多国队列研究的一部分,纳入了年龄在 50 岁及以上、初次发生脆性骨折的男性和女性患者。我们使用来自三个行政健康数据库(涵盖加泰罗尼亚、丹麦和英国)的常规收集的患者数据,估计治疗差距为初次发生骨折后 1 年内未接受 AOM 治疗的患者比例。

结果

共纳入 648369 例骨折患者。平均年龄为 70.2-78.9 岁;22.2-31.7%为男性。在丹麦,2005 年至 2015 年期间,治疗差距一直稳定在 88-90%左右。在加泰罗尼亚,治疗差距从 80%增加到 88%。在英国,治疗差距最初呈下降趋势(尽管从未低于 63%),但在研究末期,治疗差距呈上升趋势。男性的差距比女性更明显。

结论

尽管一再呼吁改善二级骨折预防,但治疗差距仍然大得不可接受,而且时间趋势表明,近年来这一问题可能越来越严重。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e06e/7360649/9ff42cbfa44c/198_2020_5358_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验